You can watch Sanofi and buy or sell other stocks, options, ETFs, and crypto commission-free!
Sanofi engages in the research, production and distribution of pharmaceutical products. It operates through the following business segments: Pharmaceuticals, Consumer Healthcare, and Human Vaccines. Read More The Pharmaceuticals segment comprises the commercial operations of the following global franchises: specialty care, diabetes & cardiovascular, established prescription products and generics, together with research, development and production activities. This segment also includes all associates whose activities are related to pharmaceuticals. The Consumer Healthcare segment comprises, for all geographical territories, the commercial operations for its Consumer Healthcare products, together with research, development and production activities dedicated to those products. The Vaccines segment comprises, for all geographical territories, the commercial operations of Sanofi Pasteur, together with research, development and production activities dedicated to vaccines. The company was founded in 1973 and is headquartered in Paris, France.
52 Week High
52 Week Low
Washington PostDec 10
Flagging French Drug Giant Tries a Familiar RemedyAll of the moves make some sense and are in line with what other large drugmakers, including his prior employer, have tried in recent years. The key to success
Regeneron Shares Swing On Sanofi's Hint At Sale Of Ownership Stake, Amendments To Drug CollaborationsRegeneron Pharmaceuticals Inc (NASDAQ: REGN) shares were rebounding Tuesday as investors digested French pharma giant and collaboration partner Sanofi SA's (NAS
Available Feb 6, Pre-Market
Sanofi says trial of sutimlimab met main goalsSanofi SA SNY, -1.59% said a Phase 3 trial of sutimlimab in people with primary cold agglutinin disease met its primary and secondary endpoints. The primary ef
Regeneron shares fall as Sanofi signals stake saleShares of Regeneron Pharmaceuticals Inc. REGN, +0.54% slipped more than 3% in premarket trading Tuesday after French partner Sanofi SA (SAN.FR) indicated it wou
Sanofi’s CEO Quits Diabetes as Cancer Breakthroughs Beckon(Bloomberg) -- Sanofi’s new chief executive, just three months into the job, is taking a scalpel to traditional areas of research to rejuvenate the sluggish Fre
Sanofi shares rally on new margin goals, narrower drug focusPARIS (Reuters) - Shares in Sanofi (SASY.PA) rose on Tuesday after the French drugmaker said it would focus on vaccines and treatments like its promising eczema
CORRECTED-Sanofi shares rally after firm narrows focus on key drugs(Corrects day in lead paragraph to Tuesday) PARIS, Dec 10 (Reuters) - Shares in Sanofi rose on Tuesday after the French drugmaker said it was discontinuing res